Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Is a 25% No Response rate inevitable ?

<< Previous

Bullboard Posts

Next >>

Comment by O12009on Jan 24, 2024 7:09am

281 Views

Post# 35842374

RE:RE:RE:Is a 25% No Response rate inevitable ?

Of course in the US, Theralase could setup their own clinics and treat patients. This would get the word out real fast letting the people know bladder cancer has a cure. They could expand the clinic as new indications are approved and become the go to place for cancer treatment.

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property